Stephen J. Forman

2022

In 2022, Stephen J. Forman earned a total compensation of $85.8K as Director at LIXTE BIOTECHNOLOGY HOLDINGS, a 81% decrease compared to previous year.

Compensation breakdown

Option Awards$63,340
Other$22,500
Total$85,840

Forman received $63.3K in option awards, accounting for 74% of the total pay in 2022.

Forman also received $22.5K in other compensation.

Rankings

In 2022, Stephen J. Forman's compensation ranked 5,621st out of 5,753 executives tracked by ExecPay. In other words, Forman earned more than 2.3% of executives.

ClassificationRankingPercentile
All
5,621
out of 5,753
2nd
Division
Manufacturing
3,067
out of 3,133
2nd
Major group
Chemicals And Allied Products
1,393
out of 1,419
2nd
Industry group
Drugs
1,300
out of 1,320
2nd
Industry
Pharmaceutical Preparations
949
out of 966
2nd
Source: SEC filing on November 4, 2024.

Forman's colleagues

We found six more compensation records of executives who worked with Stephen J. Forman at LIXTE BIOTECHNOLOGY HOLDINGS in 2022.

2022

Bas der Baan

LIXTE BIOTECHNOLOGY HOLDINGS

Director

2022

René Bernards

LIXTE BIOTECHNOLOGY HOLDINGS

Director

2022

Yun Yen

LIXTE BIOTECHNOLOGY HOLDINGS

Director

2022

Regina Brown

LIXTE BIOTECHNOLOGY HOLDINGS

Director

2022

Philip Palmedo

LIXTE BIOTECHNOLOGY HOLDINGS

Director

2022

Gil Schwartzberg

LIXTE BIOTECHNOLOGY HOLDINGS

Director

News

In-depth

You may also like